Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lavizide M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Lavish Biotech

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Lavizide M 80mg/500mg Tablet

Diabexe Duo 80mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are vital in diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carrying a rapid-acting glucose source (e.g., sugary snacks or juice) is recommended to manage hypoglycemia. Alcohol consumption should be minimized due to its hypoglycemic risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should consult their doctor before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are necessary.

Uses of Lavizide M 80mg/500mg Tablet

Non-insulin-dependent diabetes

Major Benefits of Lavizide M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Lavizide M 80mg/500mg tablets with food.

Common Side effects of Lavizide M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Lavizide M 80mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80mg/500mg Lavizide M tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Lavizide M 80mg/500mg Tablet works:

Gliclazide and metformin, combined as Lavizide M 80mg/500mg tablets, offer a dual approach to diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Lavizide M 80mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Lavizide M 80mg/500mg tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Lavizide M 80mg/500mg tablets is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Lavizide M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Lavizide M 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation should be at a low dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Lavizide M 80mg/500mg Tablet :

Should you forget a Lavizide M 80mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lavizide M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Lavizide M 80mg/500mg Tablet

Lavizide M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 diabetes.
Lavizide M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Lavizide M 80mg/500mg tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Lavizide M 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older individuals, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Lavizide M 80mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Patients with known allergies to Lavizide M 80mg/500mg Tablet components or excipients, or those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Consuming alcohol with Lavizide M 80mg/500mg tablets is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Lavizide M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Lavizide M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Lavizide M 80mg/500mg tablets can cause low blood sugar (hypoglycemia), leading to symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Lavizide M 80mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from high blood lactic acid levels. This rare side effect is more likely in older adults, those with kidney disease, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Lavizide M 80mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Patients with known allergies to Lavizide M 80mg/500mg Tablet components or excipients, or those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining Lavizide M 80mg/500mg tablets with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Lavizide M 80mg/500mg Tab...
47
MRP 57
17% off